Pfizer says FDA review time for dermatitis drug candidate has been extended

Retrieved on: 2021-04-07 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Pfizer says FDA review time for dermatitis drug candidate has been extended. View article details on hiswai:

Excerpt

Pfizer's stock is down 2.0% since the start of the year, while the S&P 500 SPX, -0.10% has gained 8.5%. Advertisement. Read Next. Read full story ...

Article found on: www.marketwatch.com